Rajagopal Murugan

Assistant Professor

Leiden University Medical Center

Netherlands

Research Interests

Explore related searches

Professors in Netherlands Professors in Immunology Immunology professors in Netherlands

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rajagopal Murugan is an Assistant Professor at Leiden University Medical Center in the Netherlands. His research focuses on vaccine safety, immunogenicity, and the development of antibody responses to infectious diseases, particularly malaria and SARS-CoV-2. His recent publications include studies on various vaccines and their immunological effects, highlighting his expertise in both experimental and clinical research.

Articles (9)

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (5)

Meta Roestenberg

Helmholtz Centre for Infection Research

NETHERLANDS

View details

Vibor Laketa

Head of Infectious Diseases Imaging Platform (IDIP)

Ruprecht Karls Universität Heidelberg

GERMANY

View details

Gillian Horn

Duke University

UNITED STATES

View details

Geert Roozen

Leiden University Medical Center

NETHERLANDS

View details

Emma Houlder

Leiden University Medical Center

NETHERLANDS

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rajagopal Murugan

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Safety, Tolerability, and Immunogenicity of the InvaplexAR-Detox Shigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial

Affinity-independent memory B cell origin of the early antibody-secreting cell response in naive individuals upon SARS-CoV-2 vaccination.

Safety and Efficacy of Immunization with a Late-Liver-Stage Attenuated Malaria Parasite

Molecular and functional properties of human Plasmodium falciparum CSP C‐terminus antibodies

Glycosylated nanoparticle-based PfCSP vaccine confers long-lasting antibody responses and sterile protection in mouse malaria model

High-density binding to Plasmodium falciparum circumsporozoite protein repeats by inhibitory antibody elicited in mouse with human immunoglobulin repertoire

From Multiplex Serology to Serolomics—A Novel Approach to the Antibody Response against the SARS-CoV-2 Proteome

A high-affinity antibody against the CSP N-terminal domain lacks Plasmodium falciparum inhibitory activity

Evolution of protective human antibodies against Plasmodium falciparum circumsporozoite protein repeat motifs

Collaborators (5)

Meta Roestenberg

Vibor Laketa

Gillian Horn

Geert Roozen

Emma Houlder

Make your next move.